Skip to main content
Erschienen in: Abdominal Radiology 10/2020

19.03.2020 | Hepatobiliary

Examining LI-RADS recommendations: should observation size only be measured on non-arterial phases?

verfasst von: Guilherme M. Cunha, Heejin Kwon, Tanya Wolfson, Anthony C. Gamst, Yong Eun Chung, Min-Jeong Kim, Sang Won Kim, Claude B. Sirlin, Kathryn J. Fowler

Erschienen in: Abdominal Radiology | Ausgabe 10/2020

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate if size measurements of liver observations is more variable in the arterial phase as suggested by LI-RADS and assess potential higher instability in categorization in this particular phase. Secondarily, to assess inter- and intra-reader agreement for size across phases.

Materials and methods

Patients with liver cirrhosis who underwent multi-arterial phase MRI between 2017 and 2018 were retrospectively selected. Three radiologists measured liver observations in each phase, independently, in a random order. Mean size between early and late arterial phases (AP), 2, 3 and 10 min delay and the number of observations crossing the LI-RADS size thresholds (10 and 20 mm) per phase were compared using McNemar’s test. Reader agreement was evaluated using intraclass correlation coefficient (ICC) and bootstrap-based comparisons. Bonferroni’s correction was applied to pairwise comparisons.

Results

94 observations (LR-3, LR-4, LR-5, and LR-M) were included. Mean sizes (mm) were late AP: 19.9 (95% CI 17.2, 24.2), 2 min delay: 19.8 (95% CI 17.1, 24.0), 3 min delay: 19.8 (95% CI 17.2, 24.0), 10 min delay: 20.2 (95% CI 17.5, 24.5) (p = 0.10–0.88). There was no difference between phases in number of observations that could have changed category due to variability in size (p = 0.546–1.000). Inter- and intra-reader agreement was excellent (ICC = 0.952–0.981).

Conclusion

Measurements of focal liver observations were consistent across all post-contrast imaging phases and we found no higher instability in LI-RADS category in any particular phase. Inter- and intra-reader agreement for size was excellent for each phase. Based on these findings, size measurement could be allowed on any post-contrast phase, including the arterial phase, if deemed appropriate by the radiologist.
Literatur
1.
Zurück zum Zitat Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019 Jan 1;156(2):477-91.CrossRef Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019 Jan 1;156(2):477-91.CrossRef
2.
Zurück zum Zitat Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016 Apr 1;150(4):835-53.CrossRef Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016 Apr 1;150(4):835-53.CrossRef
4.
Zurück zum Zitat Ayuso C, Rimola J, Vilana R, et al. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Eur J Radiol. 2018 Apr 1;101:72-81.CrossRef Ayuso C, Rimola J, Vilana R, et al. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Eur J Radiol. 2018 Apr 1;101:72-81.CrossRef
5.
Zurück zum Zitat Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018 Aug 1;68(2):723-50.CrossRef Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018 Aug 1;68(2):723-50.CrossRef
6.
Zurück zum Zitat Chernyak V, Fowler KJ, Kamaya A, et al. Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology. 2018 Sep 25;289(3):816-30.CrossRef Chernyak V, Fowler KJ, Kamaya A, et al. Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology. 2018 Sep 25;289(3):816-30.CrossRef
8.
Zurück zum Zitat Francis IR, Cohan RH, McNulty NJ, et al. Multidetector CT of the liver and hepatic neoplasms: effect of multiphasic imaging on tumor conspicuity and vascular enhancement. AJR Am J Roentgenol. 2003 May;180(5):1217-24.CrossRef Francis IR, Cohan RH, McNulty NJ, et al. Multidetector CT of the liver and hepatic neoplasms: effect of multiphasic imaging on tumor conspicuity and vascular enhancement. AJR Am J Roentgenol. 2003 May;180(5):1217-24.CrossRef
9.
Zurück zum Zitat Yacoub JH, Elsayes KM, Fowler KJ, et al. Pitfalls in liver MRI: Technical approach to avoiding misdiagnosis and improving image quality. J Magn Reson Imaging. 2019 Jan;49(1):41-58.CrossRef Yacoub JH, Elsayes KM, Fowler KJ, et al. Pitfalls in liver MRI: Technical approach to avoiding misdiagnosis and improving image quality. J Magn Reson Imaging. 2019 Jan;49(1):41-58.CrossRef
10.
Zurück zum Zitat Min JH, Kim YK, Kang TW, et al. Artifacts during the arterial phase of gadoxetate disodium-enhanced MRI: multiple arterial phases using view-sharing from two different vendors versus single arterial phase imaging. Eur Radiol. 2018 Aug 1;28(8):3335-46.CrossRef Min JH, Kim YK, Kang TW, et al. Artifacts during the arterial phase of gadoxetate disodium-enhanced MRI: multiple arterial phases using view-sharing from two different vendors versus single arterial phase imaging. Eur Radiol. 2018 Aug 1;28(8):3335-46.CrossRef
11.
Zurück zum Zitat Chernyak V, Fowler KJ, Heiken JP, Sirlin CB. Use of gadoxetate disodium in patients with chronic liver disease and its implications for liver imaging reporting and data system (LI‐RADS). J Magn Reson Imaging. 2019 May;49(5):1236-52.CrossRef Chernyak V, Fowler KJ, Heiken JP, Sirlin CB. Use of gadoxetate disodium in patients with chronic liver disease and its implications for liver imaging reporting and data system (LI‐RADS). J Magn Reson Imaging. 2019 May;49(5):1236-52.CrossRef
12.
Zurück zum Zitat Saranathan M, Rettmann DW, Hargreaves BA, Clarke SE, Vasanawala SS. Differential subsampling with cartesian ordering (DISCO): A high spatio‐temporal resolution dixon imaging sequence for multiphasic contrast enhanced abdominal imaging. J Magn Reson Imaging. 2012 Jun;35(6):1484-92.CrossRef Saranathan M, Rettmann DW, Hargreaves BA, Clarke SE, Vasanawala SS. Differential subsampling with cartesian ordering (DISCO): A high spatio‐temporal resolution dixon imaging sequence for multiphasic contrast enhanced abdominal imaging. J Magn Reson Imaging. 2012 Jun;35(6):1484-92.CrossRef
13.
Zurück zum Zitat Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977 Mar 1:159-74.CrossRef Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977 Mar 1:159-74.CrossRef
14.
Zurück zum Zitat Fowler KJ, Potretzke TA, Hope TA, Costa EA, Wilson SR. LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma. Abdom Radiol. 2018 Jan 1;43(1):149-57.CrossRef Fowler KJ, Potretzke TA, Hope TA, Costa EA, Wilson SR. LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma. Abdom Radiol. 2018 Jan 1;43(1):149-57.CrossRef
15.
Zurück zum Zitat van Lunenburg JT, Tripathi V, Chan VS, et al. Sequence and Observer Variability in Gadoxectic Acid-Enhanced MRI Lesion Measurements in Hepatocellular Carcinoma. Acad Radiol. 2019 Jul 17. van Lunenburg JT, Tripathi V, Chan VS, et al. Sequence and Observer Variability in Gadoxectic Acid-Enhanced MRI Lesion Measurements in Hepatocellular Carcinoma. Acad Radiol. 2019 Jul 17.
16.
Zurück zum Zitat Chernyak V, Flusberg M, Law A, Kobi M, Paroder V, Rozenblit AM. Liver Imaging Reporting and Data System: discordance between computed tomography and gadoxetate-enhanced magnetic resonance imaging for detection of hepatocellular carcinoma major features. J Comput Assist Tomogr. 2018 Jan 1;42(1):155-61.CrossRef Chernyak V, Flusberg M, Law A, Kobi M, Paroder V, Rozenblit AM. Liver Imaging Reporting and Data System: discordance between computed tomography and gadoxetate-enhanced magnetic resonance imaging for detection of hepatocellular carcinoma major features. J Comput Assist Tomogr. 2018 Jan 1;42(1):155-61.CrossRef
17.
Zurück zum Zitat Schellhaas B, Hammon M, Strobel D, et al. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS. Eur Radiol. 2018 Oct 1;28(10):4254-64.CrossRef Schellhaas B, Hammon M, Strobel D, et al. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS. Eur Radiol. 2018 Oct 1;28(10):4254-64.CrossRef
18.
Zurück zum Zitat Ehman EC, Behr SC, Umetsu SE, et al. Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas. Abdom Radiol. 2016 May 1;41(5):963-9.CrossRef Ehman EC, Behr SC, Umetsu SE, et al. Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas. Abdom Radiol. 2016 May 1;41(5):963-9.CrossRef
19.
Zurück zum Zitat Davenport MS, Khalatbari S, Liu PS, et al. Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging. Radiology. 2014 Feb 18;272(1):132-42.CrossRef Davenport MS, Khalatbari S, Liu PS, et al. Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging. Radiology. 2014 Feb 18;272(1):132-42.CrossRef
20.
Zurück zum Zitat Wald C, Russo MW, Heimbach JK, Hussain HK, Pomfret EA, Bruix J. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology. 2013 Feb;266(2):376-82.CrossRef Wald C, Russo MW, Heimbach JK, Hussain HK, Pomfret EA, Bruix J. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology. 2013 Feb;266(2):376-82.CrossRef
Metadaten
Titel
Examining LI-RADS recommendations: should observation size only be measured on non-arterial phases?
verfasst von
Guilherme M. Cunha
Heejin Kwon
Tanya Wolfson
Anthony C. Gamst
Yong Eun Chung
Min-Jeong Kim
Sang Won Kim
Claude B. Sirlin
Kathryn J. Fowler
Publikationsdatum
19.03.2020
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 10/2020
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-020-02490-x

Weitere Artikel der Ausgabe 10/2020

Abdominal Radiology 10/2020 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.